Stay updated on Pembrolizumab Combo in Gastro Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Gastro Cancer Clinical Trial page
- Check6 days agoChange DetectedThe study page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This signals a revision to the page content but does not change the study details.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded new help/navigation sections including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and added the recruitment note 'No longer looking for participants'. The 'Intervention/Treatment' label is introduced while the prior 'Intervention / Treatment' label is removed, and the page revision is updated to v3.6.0.SummaryDifference0.4%

- Check27 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor update to the page history rather than substantive content changes.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision tag v3.5.4 has been added, replacing the previous v3.5.3 in the page's revision history. This indicates a software/maintenance update to the study page.SummaryDifference0.1%

- Check70 days agoChange DetectedClinicalTrials.gov’s page footer/update label changed from revision **v3.5.0** to **v3.5.3**, reflecting a site/version update without changing the study record content.SummaryDifference0.1%

- Check106 days agoChange DetectedThe page shows revision v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Gastro Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.